Target intelligence / Profile preview

Ultraviolet B photon and short-wave Ultraviolet A photon (UVB and short-wave UVA)

Target
UVB and short-wave UVA
Molecular classification
Other
01

Overview

UVB and short-wave UVA photons are forms of ultraviolet electromagnetic radiation with wavelengths ranging from 280–320 nm (UVB) and 320–340 nm (short-wave UVA, also called UVA2)[3][7][8]. While neither is a molecule or classical therapeutic target, both penetrate the skin to different depths and trigger diverse biological effects. UVB photons have higher energy and are primarily absorbed in the epidermis, causing direct DNA damage (notably cyclobutane pyrimidine dimers and 6-4 photoproducts), leading to sunburn, immunosuppression, and increased risk of skin cancer[2][4][7]. Short-wave UVA photons penetrate deeper into the dermis, generating reactive oxygen species that induce oxidative stress, collagen breakdown, photoaging, and potentially indirect DNA damage[2][3][8]. Both types of UV irradiation can activate neuroendocrine and immune responses, and their systemic effects may extend beyond the skin to involve hormonal and nervous system regulation[1][5]. The medical relevance of these photons primarily concerns understanding their contribution to skin disease and systemic health via environmental exposure, rather than as candidates for drug targeting.

Other names
Ultraviolet B radiationUVBShort-wave ultraviolet A radiationUVA2 (320–340 nm)UVB (280–320 nm)
02

Biological functions

DNA damage inductionOxidative stress generationModulation of cutaneous immune responseHormonal and neuroendocrine activationVitamin D synthesis
03

Disease associations

Skin cancer (carcinogenesis, including melanoma and non-melanoma)PhotoagingInflammationAutoimmune modulationEye damage (e.g., photokeratitis, cataract)Other cutaneous and systemic effects
04

Safety considerations

Carcinogenicity (skin cancer induction from DNA damage)Acute phototoxicity (sunburn)Chronic skin aging (photoaging)ImmunosuppressionRisk of ocular damage

Beyond the preview

Go deeper on Ultraviolet B photon and short-wave Ultraviolet A photon (UVB and short-wave UVA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ultraviolet B photon and short-wave Ultraviolet A photon (UVB and short-wave UVA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call